Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2019 08:55 ET | Source: Jamieson Bondarenko

Bondarenko Acquires 16.2% Beneficial Ownership of BriaCell Therapeutics Corp.

TORONTO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 3,154,302 common shares (the “Shares”) of BriaCell Therapeutics...
May 17, 2019 09:24 ET | Source: Jamieson Bondarenko

Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell Therapeutics Corp.

TORONTO, May 17, 2019 (GLOBE NEWSWIRE) -- Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 1,698,000 common shares (the “Shares”) of BriaCell Therapeutics...
March 25, 2019 21:26 ET | Source: Jamieson Bondarenko

Jamieson Bondarenko Acquires 5,000,000 Common Shares of BriaCell Therapeutics Corp.

TORONTO, March 25, 2019 (GLOBE NEWSWIRE) -- Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 5,000,000 common shares (the “Shares”) of BriaCell Therapeutics...
February 12, 2019 19:57 ET | Source: Jamieson Bondarenko

Jamieson Bondarenko Acquires 11.0% Beneficial Ownership of BriaCell Therapeutics Corp.

TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 2,000,000 common shares (the “Shares”) of BriaCell Therapeutics...